Patent · US Expired

Tumor localization and therapy with labeled anti-CEA antibody

US4348376A · kind A · utility

143Cited by
4References
39Claims
0Family size

Inventor

Key dates

Filing dateMar 3, 1980
Grant dateSep 7, 1982
Priority date
Expiry dateMar 3, 2000

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2123/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Improved methods are provided for using radiolabeled antibodies to carcinoembronic antigen (CEA) to locate, diagnose and stage CEA-containing tumors by external photoscanning, whereby significantly increased resolution, convenience and/or efficiency of operation may be achieved. A method is provided for using highly specific radiolabeled anti-CEA antibodies for tumor therapy. An injectable composition and radiolabeled antibodies are provided for use in the method of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.